BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17474982)

  • 1. Fully-spliced HIV-1 RNAs are reverse transcribed with similar efficiencies as the genomic RNA in virions and cells, but more efficiently in AZT-treated cells.
    Houzet L; Morichaud Z; Mougel M
    Retrovirology; 2007 May; 4():30. PubMed ID: 17474982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.
    Houzet L; Paillart JC; Smagulova F; Maurel S; Morichaud Z; Marquet R; Mougel M
    Nucleic Acids Res; 2007; 35(8):2695-704. PubMed ID: 17426127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
    Jacquenet S; Decimo D; Muriaux D; Darlix JL
    Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.
    Zhang H; Dornadula G; Orenstein J; Pomerantz RJ
    J Hum Virol; 2000; 3(3):165-72. PubMed ID: 10881997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural endogenous reverse transcription of simian immunodeficiency virus.
    Dornadula G; Zhang H; Bagasra O; Pomerantz RJ
    Virology; 1997 Jan; 227(1):260-7. PubMed ID: 9007084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance.
    Goldschmidt V; Didierjean J; Ehresmann B; Ehresmann C; Isel C; Marquet R
    Nucleic Acids Res; 2006; 34(1):42-52. PubMed ID: 16394022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication.
    Joshi PJ; North TW; Prasad VR
    Mol Ther; 2005 May; 11(5):677-86. PubMed ID: 15851006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide-mediated retroviral RNase H activation leads to reduced HIV-1 titer in patient-derived plasma.
    Heinrich J; Mathur S; Matskevich AA; Moelling K
    AIDS; 2009 Jan; 23(2):213-21. PubMed ID: 19098491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 reverse transcription initiation: a potential target for novel antivirals?
    Abbink TE; Berkhout B
    Virus Res; 2008 Jun; 134(1-2):4-18. PubMed ID: 18255184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
    Hiratou T; Miyano-Kurosaki N; Gushima H; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):715-8. PubMed ID: 11563099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a nuclear ribonucleoprotein particle which contains incompletely spliced HIV-1 RNAs.
    Bøe SO; Kalland KH
    Biochem Biophys Res Commun; 2000 Feb; 268(2):509-13. PubMed ID: 10679235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization.
    Song R; Kafaie J; Yang L; Laughrea M
    J Mol Biol; 2007 Aug; 371(4):1084-98. PubMed ID: 17599354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of heteroclite subgenomic RNAs associated with PRRSV infection.
    Yuan S; Murtaugh MP; Schumann FA; Mickelson D; Faaberg KS
    Virus Res; 2004 Sep; 105(1):75-87. PubMed ID: 15325083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural endogenous reverse transcription of HIV type 1.
    Zhang H; Dornadula G; Pomerantz RJ
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S93-5. PubMed ID: 9581892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.
    Paolucci S; Baldanti F; Campanini G; Cancio R; Belfiore A; Maga G; Gerna G
    Antiviral Res; 2007 Nov; 76(2):99-103. PubMed ID: 17640745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
    Marchand B; White KL; Ly JK; Margot NA; Wang R; McDermott M; Miller MD; Götte M
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2911-9. PubMed ID: 17517852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral RNAs detected in virions of porcine adenovirus type 3.
    Xing L; Tikoo SK
    Virology; 2004 Apr; 321(2):372-82. PubMed ID: 15051396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paramyxovirus Sendai virus C proteins are essential for maintenance of negative-sense RNA genome in virus particles.
    Irie T; Nagata N; Yoshida T; Sakaguchi T
    Virology; 2008 May; 374(2):495-505. PubMed ID: 18252261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication.
    Sakuragi J; Sakuragi S; Shioda T
    J Virol; 2007 Aug; 81(15):7985-92. PubMed ID: 17507464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.